Navigation Links
Mayo Clinic researchers: Insulin-boosting medication does not impair ability to survive heart attack
Date:11/5/2007

ORLANDO, Fla. -- Mayo Clinic researchers helped clarify a growing concern about the link between diabetes mellitus treatments and heart attack with the first large, population-based study showing that a group of common medications does not reduce diabetic patients heart attack survival rates. These results were presented today at the American Heart Associations Scientific Sessions 2007 in Orlando, Fla.

The drugs studied are called sulfonylureas and include several commonly used pills to increase insulin release to lower blood sugar. Second-generation sulfonylureas -- known collectively as SU2 -- include glimepiride (Amaryl), glipizide (Glucotrol, Glucotrol XL), and glyburide (DiaBeta, Micronase, Glynase).(1)

Significance of the Mayo Clinic Study

The prevalence of diabetes mellitus is growing rapidly, and physicians need evidence for their treatment recommendations. Worldwide, the number of diabetics is projected to more than double in three decades, from 171 million in 2000 to 366 million in 2030.(2) Many patients with diabetes are at increased risk for heart failure. This complicates their treatment, and has raised concern in recent years among some physicians that SU2s may impair the hearts ability to withstand stress, thus reducing patients ability to survive heart attacks, says Veronique Roger, M.D., M.P.H., the Mayo cardiologist and epidemiologist who led the study.

The Mayo study is the first to use a broad population of community members to extract information about the impact of various diabetes treatments on patients health after heart attack. The Mayo group evaluated the outcome of heart attack in two groups: people who had diabetes and those who did not. Group members were similar in terms of age, gender and lifestyle habits such as smoking. In the diabetes group, researchers tracked patient outcome after heart attack in patients taking three different treatment approaches to lowering blood sugar: SU2 dr
'/>"/>

Contact: Traci Klein
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Radiologists encouraged to look beyond cancer for clinically unseen diseases
3. Clinical depression linked to abnormal emotional brain circuits
4. Preclinical study suggests organ-transplant drug may aid in lupus fight
5. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
6. AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic
7. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
8. MinuteClinic Becomes Participating Provider with Assurant Health
9. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
10. Acupuncturists Relocation Tightens Relationship With Fertility Clinic
11. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... XenaCare Holdings has announ...rthritis Foundation, one of the largest nonprofit ...public health education. , ...naCare Holdings, Inc. (OTCBB: XCHO), a company spe... of consumer healthcare products, has announced to...
(Date:11/27/2009)... Voyant Health™ announc...gan) has licensed its TraumaCad Enterprise orthope...orkflow solution. , (PRWE...nced today that Spectrum Health (Grand Rapids, Mic...pedic templating solution and its TraumaCad Extend...
(Date:11/26/2009)... , NEW YORK, Nov. 27 With col... ever to employ good practices to control the spre... to be proactive not only to keep ourselves health...," said Eileen Finerty, RN, MS, CIC (certified in ... control and occupational health at Hospital for S...
(Date:11/26/2009)...age that,s too big or too heavy can lead to strain...Day News) -- There may be nothing wrong with stuff...t want to do the same thing with your suitcase as ...people were treated in 2008 in U.S. hospital emerg...dical facilities for luggage-related injuries, suc...
(Date:11/26/2009)... Research Triangle Dental (RT...l North Carolina, today announced the expansion of...LUMINEER Dentist, Dr. Doug Macmillan. , ...riangle Dental is pleased to announce that Dr. Dou...ecently completed an additional advanced training ...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...gency Calls For More Public and Private Investment...ON, June 20 World Vision announced,today the laun...leading,cause of child deaths worldwide., Transmi...ldren in sub-Saharan Africa. Each year, more than ...
...ad, certain immune cells may be key, new study sho... Measles may be one of the most common contagious ... it does not spread through one,s body via airways...tigation , reported that the measles virus instead...
...NAPOLIS, June 20 The board of directors,of Eli Li...idend for the,third quarter of 2008 of $0.47 a sha...ividend as was paid in the first and second quarte...rd,at the close of business on August 15, 2008., ...
...N FRANCISCO (June 20, 2008) Turmeric, an Asian sp...se in reducing inflammation, healing wounds and re...nflammation plays a big role in many diseases and ...i Berrie Diabetes Center at Columbia University Me...
...ief is universal, and most of us will probably exp... lives, usually with the death of a loved one. In ...or a substantial minority, it,s impossible to let ...some grieve and ultimately adapt, while others can...
...ssion, stress could speed AIDS progression, review...(HealthDay News) -- Stress and depression may make...ed with HIV, according to three new reviews of the... But the research strongly points to a link, said ...
Other Medicine News:Health News:World Vision Launches Initiative to Combat Malaria 2Health News:World Vision Launches Initiative to Combat Malaria 3Health News:Measle's Spread Doesn't Depend on Airways 2Health News:Common cooking spice shows promise in combating diabetes and obesity 2Health News:Study shows that chronic grief activates pleasure areas of the brain 2Health News:A Healthy Mind Can Help Fight HIV 2Health News:A Healthy Mind Can Help Fight HIV 3
(Date:11/25/2009)...PRNewswire/ -- According to Millennium Research Gr...ogy market intelligence, the nearly $3 billion US ...o see rapid growth over the next five years despit...for Trauma Devices 2010 report finds that this ...ve years, with competitors introducing specialized...
(Date:11/25/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Pain Management - Global Trends ,, ...nt---Global-Trends.html ,, Widespread availabi...t clinics, and the advent of new drugs have accele...rket. Healthcare reforms and reimbursement structu...
(Date:11/25/2009)... Nov. 25 HeartWare Inter...ng innovator and provider of less invasive, miniat...izing the treatment of advanced heart failure, tod...tor presentation at the 21st Annual Piper Jaffray ..., December 2, 2009. The conference is being held a...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2Study Casts Doubt on Low IQs Role in Early Death 50630 1Study Casts Doubt on Low IQs Role in Early Death 50630 2Connectyx Technologies Holdings Group Inc Signs an Agreement with Healthy Directions LLC Americas Largest Publisher of Alternative and Complementa 50627 1Connectyx Technologies Holdings Group Inc Signs an Agreement with Healthy Directions LLC Americas Largest Publisher of Alternative and Complementa 50627 2Is Financial Infidelity a Threat to Your Marriage 3F Psychiatrist Says It Can Be More Devastating Than an Affair 50624 1Is Financial Infidelity a Threat to Your Marriage 3F Psychiatrist Says It Can Be More Devastating Than an Affair 50624 2
...)--May 2, 2007 - Acorda Therapeutics, Inc.(R),(Nas...nical trial,of Fampridine-SR in people with multip...logy meeting. Andrew Goodman, M.D.,Director of th...ochester, presented top-line results on walking ab...subject global impressions.,Dr. Goodman also prese...
...sitive Data in Nonclinical (IND) In- Vitro,Studies... 2007 (PRIME NEWSWIRE) -- Samaritan,Pharmaceutical...,is pleased to announce positive results were att...testing of Caprospinol (SP-233),with well recogni...ch results are imperfect predictors,of clinical re...
Other Medicine Technology:Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 2Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 3
Single Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-340
Single Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-330A
Single Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-320
Dual Pressure Sensor Intravascular Mikro-Tip Pressure Catheters with Lumen; SPC-784A
Medicine Products: